Clinical Trial Update: Maternal Hyperoxygenation in Congenital Heart Disease [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on maternal hyperoxygenation for congenital heart disease (hypoplastic left heart syndrome) across Phase 1 and Phase 2, status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoplastic Left Heart Syndrome

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Hypoplastic Left Heart Syndrome | Phase 1, Phase 2 | Status: COMPLETED